Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.

Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid ...

Virologist Beata Halassy successfully treated her breast cancer using oncolytic virotherapy, raising ethical questions about self-experimentation in medicine. While her case highlights the potential ...

A new global initiative is working to create a clear, consistent gene editing lexicon for the haemophilia community. This ...

A virologist named Beata Halassy recently made headlines after publishing a report of successfully treating her own breast ...

Genetic studies have revealed that when male mosquitoes lose their hearing, they also lose their sex lives. The surprising ...

Study links prenatal THC exposure to increased opioid addiction risk in later life, raising concerns for cannabis use during ...

A new study presents "Evo" – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from molecular to genome scale, with unparalleled accuracy. Evo's ability to ...

Selenoproteins are crucial for several biological functions, including the breakdown of harmful substances, immune system ...

Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after prior CD19 ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

From the first approved CRISPR treatment to AI designing its own computer chips, check out this week's awesome tech stories ...